Brian O Mahony/X
Apr 26, 2026, 06:28
Brian Mahony: Real-World Positioning of Rebalancing Agents
Brian Mahony,CEO of Irish Haemophilia Society, former President of WFH and EHC,shared a post on X:
“Mahlangu on re-balancing agents WFH Congress 2026.
Bypassing agents increase thrombosis risk.
Avoid stacking therapies and apply strict protocol driven care.
Some of the thrombosis cases seen were where protocol not observed 1/2.”
See more in the gallery.
Stay updated on all scientific advances with Hemostasis Today.
-
May 13, 2026, 15:49Alison Dougall: Oral Health and Cardiovascular Risk in Bleeding Disorders
-
May 13, 2026, 15:38International Journal of Stroke: Oral Anticoagulants and DOAC–Antiplatelet Therapy Are Associated with Increased Major Bleeding Risk
-
May 13, 2026, 15:19Papa Heme։ Causes of Isolated Prolonged aPTT Without Bleeding
-
May 13, 2026, 15:10Wolfgang Miesbach: Rethinking Bleeding Risk in Anticoagulation
-
May 13, 2026, 15:09Veronica Sanchez: Better Cardiovascular Health Helps Lower Heart Attack Risk
-
May 13, 2026, 15:07Tung Nguyen Thanh: New Perspective on Thrombosis in Hematological Malignancies in Vietnam
-
May 13, 2026, 15:03Haji Siyamuddin Ansari: The Key Difference Between Plasma and Serum
-
May 13, 2026, 14:45Masoabi Sefojane: The Cost of a 35-Year Diagnosis Delay
-
May 13, 2026, 14:39Ahmed Mohsen: Managing DVT During Pregnancy and Lactation